Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia. Br J Haematol 2010 Aug;150(4):480-1 PMID: 20456357

Pubmed ID

20456357

DOI

10.1111/j.1365-2141.2010.08218.x

Author List

Olteanu H, Harrington AM, Ramirez S, Kroft SH, Hari P

Authors

Parameswaran Hari MD Chief, Professor in the Medicine department at Medical College of Wisconsin
Alexandra M. Harrington MD Associate Professor in the Pathology department at Medical College of Wisconsin
Steven Howard Kroft MD Interim Chair, Professor in the Pathology department at Medical College of Wisconsin




Scopus

2-s2.0-77955163811   2 Citations

MESH terms used to index this publication - Major topics in bold

Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Antineoplastic Agents
Drug Administration Schedule
Female
Humans
Leukemia, Large Granular Lymphocytic
Middle Aged
Purpura, Thrombocytopenic, Idiopathic
jenkins-FCD Prod-321 98992d628744e349846c2f62ac68f241d7e1ea70